explore -WSS

explore

author：entertainment 2025-09-29 12:30:08 - browse：2

Warning sign illustration made of 0s and 1s. -- first opinion coverage from sTAT — Adobe

Big businesses poised to profit from the advance of artificial intelligence in health care are pushing back against newly proposed federal rules meant to increase oversight and fairness of AI tools used to help make decisions about patient care.

The opposition, which includes Google and Amazon as well as large health care providers, insurers, and medical software vendors, is focused on an attempt to put tighter guardrails around the use of AI by the Office of the National Coordinator for Health Information Technology.

The agency wants to require developers of electronic health records and other health software to provide users with details about the training and testing of predictive models that draw data from their systems, or are hosted within them. It also wants developers to assess and publicly disclose potential risks and create a way for clinicians and other users to report problems.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Ohio still needs to do more to protect the right to abortion

leisure time

explore

WSS

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Morphosys mixed study results for blood cancer drug

Carbon Health diabetes program, a test of data

Type 2 diabetes prevention programs work at large scale: study

A letter from the executive editor: STAT UnitedHealth investigation

What health policies could hitch a ride on a spending bill?

entertainment

explore

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Experimental asthma app from Apple and Anthem shows promise

In Memoriam: Notable people who died in 2023

Hospitals look to new technology to keep health care workers safe

Virginia high school admissions case could be legal follow

Wegovy, Zepbound and weight loss drugs that preserve muscle

Continuity nursing helped my family in our darkest PICU moments

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Peter Hotez and the public health issue of online harassment

Childhood cancer progress stalls for Black, Hispanic kids: Report

explore

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Today's health inequities arise from racist U.S. history, say experts

Ohio still needs to do more to protect the right to abortion

Study suggests Covid rebound is far more common with Paxlovid than without

Study suggests Covid rebound is far more common with Paxlovid than without

In key trial, Verve's treatment lowers cholesterol levels in patients

focus

leisure time

explore

entertainment